ACORN CAPITAL ADVISORS, LLC - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, ACORN CAPITAL ADVISORS, LLC held in its portfolio 21 assets valued at $295,133,293 (i.e. $295.13M).
The most valuable assets in the portfolio included: TERNS PHARMACEUTICALS INC ($70.55M), CG ONCOLOGY INC ($46.98M), and UROGEN PHARMA LTD ($33.92M).
The chart below shows the top 10 valuable assets, and the table below shows the top 21 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
ACORN CAPITAL ADVISORS, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| TERNS PHARMACEUTICALS INC | 1746264 | 70549066 | COM |
| CG ONCOLOGY INC | 1131501 | 46979903 | COM |
| UROGEN PHARMA LTD | 1448420 | 33921996 | COM |
| TREVI THERAPEUTICS INC | 2144844 | 26853447 | COM |
| PUMA BIOTECHNOLOGY INC | 4131299 | 24581229 | COM |
| CANDEL THERAPEUTICS INC | 2580517 | 14579921 | COM |
| CYBIN INC | 1573023 | 12873935 | COM NEW |
| VERASTEM INC | 1469153 | 11341861 | COM |
| BICARA THERAPEUTICS | 643382 | 10828113 | COM |
| PROTARA THERAPEUTICS INC | 1752115 | 9338773 | COM STK |
| ONKURE THERAPEUTICS INC | 2839674 | 8235055 | CLASS A COM |
| CARDIF ONCOLOGY INC | 1962084 | 5513456 | COM |
| ATHIRA PHARMA INC. | 501739 | 3798164 | COMMON STOCK |
| JASPER THERAPEUTICS | 1786492 | 3269280 | COM |
| AURA BIOSCIENCES INC | 595744 | 3246805 | COM |
| WHITEHAWK THERAPEUTICS INC | 1139363 | 2757258 | COM |
| BIOATLA INC | 4835111 | 2756013 | COM |
| Q32 BIO INC. | 493425 | 1638171 | COM |
| X4 PHARMACEUTICALS INC | 273349 | 1093398 | COM |
| ACRIVON THERAPEUTICS INC | 405237 | 976622 | COMMON STOCK |
| VYNE THERAPEUTICS INC | 1425 | 827 | COM |
Popular Topics:
Find us
Copyright © Beautify Data LLC. All Rights Reserved.